These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8454922)

  • 21. [A case of hyperparathyroid bone disease and the review of renal osteodystrophy].
    Soejima M; Takasugi M; Kuroiwa A; Okajima T; Zeze F
    Fukuoka Igaku Zasshi; 1992 Jul; 83(7):319-21. PubMed ID: 1398425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parathyroidectomy Increases Heart Rate Variability and Leptin Levels in Patients with Stage 5 Chronic Kidney Disease.
    Jiang Y; Shen Z; Zhang J; Xing C; Zha X; Shen C; Zeng M; Yang G; Mao H; Zhang B; Yu X; Sun B; Ouyang C; Ge Y; Zhang L; Cheng C; Zhang J; Yin C; Chen H; Wang N
    Am J Nephrol; 2016; 44(3):245-54. PubMed ID: 27598394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Long-term effects of a combination of 25-hydroxycholecalciferol and 1-alpha-hydroxycholecalciferol on osteodystrophy in chronic hemodialysis patients].
    Sebert JL; Marie A; Kuntz D; Marie P; Gueris J; Smadja A; Fournier A; Quichaud J
    Rev Rhum Mal Osteoartic; 1981; 48(7-9):535-41. PubMed ID: 7291931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of 1-alpha-hydroxyvitamin D 3 treatment of osteodystrophy in uremic patients treated with periodic hemodialysis].
    Palmieri P; Albertazzi A; Cappelli P; Di Paolo B
    G Clin Med; 1981 Jul; 62(7):443-60. PubMed ID: 7308629
    [No Abstract]   [Full Text] [Related]  

  • 25. 1,25-dihydroxycholesterol treatment of long-term haemodialysed patients with renal osteodystrophy.
    Váry L
    Int Urol Nephrol; 1980; 12(3):241-7. PubMed ID: 7251289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term experience of alfacalcidol in renal osteodystrophy.
    Sharman VL; Brownjohn AM; Goodwin FJ; Hately W; Manning RM; O'Riordan JH; Papapoulos SE; Marsh FP
    Q J Med; 1982; 51(203):271-8. PubMed ID: 7146311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin D supplementation after parathyroidectomy: effect on bone mineral density-a randomized double-blind study.
    Norenstedt S; Pernow Y; Zedenius J; Nordenström J; Sääf M; Granath F; Nilsson IL
    J Bone Miner Res; 2014 Apr; 29(4):960-7. PubMed ID: 24115138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of renal osteodystrophy: physiopathology and secondary effects].
    Haldimann B; Flury W
    Schweiz Med Wochenschr; 1977 Aug; 107(32):1113-8. PubMed ID: 333572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal osteodystrophy in children with chronic renal failure: an unexpectedly common and incapactating complication.
    Hsu AC; Kooh SW; Fraser D; Cumming WA; Fornasier VL
    Pediatrics; 1982 Nov; 70(5):742-50. PubMed ID: 6982452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Symptomatic renal osteodystrophy after renal transplantation: treatment with 1-alpha-hydroxycholecalciferol.
    Williams PS; Hillis AN; Carty AJ; Sells RA; Bone JM
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2227-8. PubMed ID: 3274500
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical picture, diagnosis and therapy of renal osteodystrophy].
    Bombor H
    Z Urol Nephrol; 1977 Aug; 70(8):603-7. PubMed ID: 335702
    [No Abstract]   [Full Text] [Related]  

  • 32. Surgical treatment for renal hyperparathyroidism--report of 23 cases.
    Marubayashi S; Fukuda Y; Watanabe H; Matsusaka C; Ohshiro Y; Nitta K; Yahata H; Asahara T; Dohi K; Harada S
    Hiroshima J Med Sci; 1992 Mar; 41(1):7-11. PubMed ID: 1572807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Radiologic surveillance of uremic osteodystrophy after parathyroidectomy].
    Orrei MG; Catizone L; Pavlica P; Veneziano S; Viglietta G
    Radiol Med; 1986; 72(7-8):521-7. PubMed ID: 3737984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered pattern of calcium kinetics in hemodialysis patients after parathyroidectomy.
    Kurz P; Ewald U; Tsobanelis T; Roth P; Werner E; Vlachojannis J; Grützmacher P
    ASAIO Trans; 1990; 36(3):M452-6. PubMed ID: 2252725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inconsistency in radiographic evaluation of progressive renal osteodystrophy.
    Guerra LE; Amato JA; Maher JF
    Clin Nephrol; 1979 Jun; 11(6):307-12. PubMed ID: 477048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fracture risk after parathyroidectomy among chronic hemodialysis patients.
    Rudser KD; de Boer IH; Dooley A; Young B; Kestenbaum B
    J Am Soc Nephrol; 2007 Aug; 18(8):2401-7. PubMed ID: 17634437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of treatment with 1--alpha-hydroxyvitamin D3 in osteodystrophy in uremic patients undergoing periodical hemodialysis].
    Albertazzi A; Palmieri PF; Del Rosso G; Spisni C; Evangelista M
    Minerva Nefrol; 1980; 27(4):631-3. PubMed ID: 7254690
    [No Abstract]   [Full Text] [Related]  

  • 38. Bone mineral recovery after parathyroidectomy in patients with primary and renal hyperparathyroidism.
    Abdelhadi M; Nordenström J
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3845-51. PubMed ID: 9814456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of 1,25(OH)2D3 and 24,25(OH)2D3 in the long-term treatment of renal osteodystrophy.
    Muirhead N; Catto GR; Edward N; Fraser RA; O'Riordan JL; Papapoulos SE; Adami S
    Proc Eur Dial Transplant Assoc; 1980; 17():543-7. PubMed ID: 6972529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal osteodystrophy.
    Delmez JA
    Curr Ther Endocrinol Metab; 1994; 5():504-8. PubMed ID: 7704782
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.